Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- H. Lee Moffitt Cancer Center
Tampa, Florida, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital
Baltimore, Maryland, United States
- National Cancer Institute
Bethesda, Maryland, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Herbert Irving Comprehensive Cancer Center of Columbia University
New York, New York, United States
- Nyu Langone Medical Center
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Providence Portland Medical Center
Portland, Oregon, United States
- University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
- Virginia Mason Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Sept 2011
- Primary completion
- 31 Oct 2016
- Completion
- 10 Feb 2017
- Last update posted
- 8 May 2018
- Registered enrollment
- 93
- Registry id
- NCT01417000
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.